客户视角：用户发表的文章43
发表时间：2024-07-31 15:26 Publication List 1. Wang B, Tang M, Chen Q, et al. Delivery of mRNA Encoding Interleukin-12 and a Stimulator of Interferon Genes Agonist Potentiates Antitumor Efficacy through Reversing T Cell Exhaustion [J]. ACS Nano, 2024. DOI: https://doi.org/10.1021/acsnano.4c00063 2. Lyu Y, Yang X, Yang L, et al. Lipid nanoparticle-mediated hepatocyte delivery of siRNA and silibinin in metabolic dysfunction-associated steatotic liver disease[J]. Journal of controlled release: official journal of the Controlled Release Society, S0168-3659 (24) 00442-5. DOI:https://doi.org/10.1016/j.jconrel.2024.07.011 3. Xu, Z, Ze X, Jing W, et al. Novel mRNA adjuvant ImmunER enhances prostate cancer tumor-associated antigen mRNA therapy via augmenting T cell activity. OncoImmunology 13.1 (2024): 2373526. DOI:https://doi.org/10.1080/2162402X.2024.2373526 4. Run M, Yu L, Yi W, et al. The dynamic process of mRNA delivery by lipid nanoparticles in vivo[J]. Nano Today, 57(2024): 102325. DOI: https://doi.org/10.1016/j.nantod.2024.102325 5. Zeng J, Fang Y, Zhang Z, et al. Antitumor activity of Z15-0-2, abispecific nanobody targeting PD-1 and CTLA-4 [J]. Oncogene, 2024: 1-9. DOI:https://doi.org/10.1038/s41388-024-03066-5 6. Zhao H, Shao X, Yu Y, et al. A therapeutic hepatitis B mRNA vaccine with strong immunogenicity and persistent virological suppression [J]. npj Vaccines, 2024, 9(1): 22. DOI:https://doi.org/10.1038/s41541-024-00813-3 7. Wang S, Zhu Z, LiJ. Pharmacokinetic Analyses of a Lipid Nanoparticle- Encapsulated mRNA-Encoded Antibody against Rift Valley Fever Virus [J]. Molecular Pharmaceutics, 2024. DOI:https://doi.org/10.1021/acs.molpharmaceut.3c01016 8. Du P, Huang L, Fang Y, et al. Broad-spectrum Delta-BA. 2 tandem-fused heterodimer mRNA vaccine delivered by lipopolyplex[J]. Plos Pathogens, 2024, 20(4): e1012116. DOI:https://doi.org/10.1371/journal.ppat.1012116 9. Huang L, ZhaoF, He M, et al. An inoculation site-retained mRNA vaccine induces robust immune responses against SARS-CoV-2 variants [J]. Journal of Controlled Release, 2024, 366: 479-493. DOI:https://doi.org/10.1016/j.jconrel.2024.01.002 10. Duan Z, Liang Y, Sun J, et al. An engineered Cas12i nuclease that is an efficient genome editing tool in animals and plants [J]. The Innovation, 2024. DOI:https://doi.org/10.1016/j.xinn.2024.100564 11. Zhao Y, Fan B, Song X, et al. PEDV-spike-protein-expressing mRNA vaccine protects piglets against PEDV challenge[J]. Mbio, 2024, 15(2): e02958-23. DOI:https://doi.org/10.1128/mbio.02958-23 12. Yang J, Zhu J, Sun J, et al. Intratumoral delivered novel circular mRNA encoding cytokines for immune modulation and cancer therapy [J]. Molecular Therapy- Nucleic Acids, 2022, 30: 184-197. DOI:https://doi.org/10.1016/j.omtn.2022.09.010 13. Tai W, Yang K, Liu Y, et al. A lung-selective delivery of mRNA encoding broadly neutralizing antibody against SARS-CoV-2 infection [J]. Nature Communications, 2023, 14(1): 8042. DOI:https://doi.org/10.1038/s41467-023-43798-8 14. Xu Y, HuY, Xia H, et al. Delivery of mRNA Vaccine with 1, 2-Diesters-Derived Lipids Elicits Fast Liver Clearance for Safe and Effective Cancer Immunotherapy [J]. Advanced Healthcare Materials, 2024, 13(5): 2302691. DOI:https://doi.org/10.1002/adhm.202302691 15. Shi L, Gu H. Cell membrane-camouflaged liposomes and neopeptide-loaded liposomes with TLR agonist R848 provides a prime and boost strategy for efficient personalized cancer vaccine therapy [J]. Nanomedicine: Nanotechnology, Biology and Medicine, 2023, 48: 102648. DOI:https://doi.org/10.1016/j.nano.2022.102648 16. Wan J, Yang J, Wang Z, et al. A single immunization with core–shell structured lipopolyplex mRNA vaccine against rabies induces potent humoral immunity in mice and dogs [J]. Emerging Microbes & Infections, 2023, 12(2): 2270081. DOI:https://doi.org/10.1080/22221751.2023.2270081 17. Xiong F, Zhang C, Shang B, et al. An mRNA-based broad-spectrum vaccine candidate confers cross-protection against heterosubtypic influenza A viruses [J]. Emerging Microbes & Infections, 2023, 12(2): 2256422. DOI:https://doi.org/10.1080/22221751.2023.2256422 18. Xia H, He Y R, Zhan XY, et al. Mpox virus mRNA-lipid nanoparticle vaccine candidates evoke antibody responses and drive protection against the Vaccinia virus challenge in mice [J]. Antiviral Research, 2023, 216: 105668. DOI:https://doi.org/10.1016/j.antiviral.2023.105668 19. Miao H, Huang K, Li Y, et al. Optimization of formulation and atomization of lipid nanoparticles for the inhalation of mRNA[J]. International Journal of Pharmaceutics, 2023, 640: 123050. DOI:https://doi.org/10.1016/j.ijpharm.2023.123050 20. Wang X, Liu C, RcheulishviliN, et al. Strong immune responses and protection of PcrV and OprF-I mRNA vaccine candidates against Pseudomonas aeruginosa [J]. npj Vaccines, 2023, 8(1): 76. DOI:https://doi.org/10.1038/s41541-023-00672-4 21. Huang K, LiN, Li Y, et al. Delivery of circular mRNA via degradable lipid nanoparticles against SARS-CoV-2 delta variant [J]. bioRxiv, 2022: 2022.05. 12.491597. DOI:https://doi.org/10.1101/2022.05.12.491597 22. Su C, WenY, Geng X, et al. A Quadrivalent mRNA immunization elicits potent immune responses against vaccinia and monkeypox viral antigens–a step closer to a broad orthopoxvirus vaccine [J]. BioRxiv, 2023: 2023.04. 23.537951. DOI:https://doi.org/10.1101/2023.04.23.537951 23. Zhang H, Zhang L, LinA, et al. Algorithm for optimized mRNA design improves stability and immunogenicity [J]. Nature, 2023, 621(7978): 396-403. DOI:https://doi.org/10.1038/s41586-023-06127-z 24. Shen Z, Liu C, Wang Z, et al. Development of a Library of Disulfide Bond- Containing Cationic Lipids for mRNA Delivery [J]. Pharmaceutics, 2023, 15(2): 477. DOI:https://doi.org/10.3390/pharmaceutics15020477 25. Fan N, Chen K, Zhu R,et al. Manganese-coordinated mRNA vaccines with enhanced mRNA expression and immunogenicity induce robust immune responses against SARS-CoV-2 variants [J]. Science Advances, 2022, 8: eabq3500. DOI:https://doi.org/10.1126/sciadv.abq3500 26. Mao S, LiS, Zhang Y, et al. A highly efficient needle-free-injection delivery system for mRNA-LNP vaccination against SARS-CoV-2 [J]. Nano Today, 2023, 48: 101730. DOI:https://doi.org/10.1016/j.nantod.2022.101730 27. Yang R, DengY, Huang B, et al. A core-shell structured COVID-19 mRNA vaccine with favorable biodistribution pattern and promising immunity [J]. Signal transduction and targeted therapy, 2021, 6(1): 213. DOI:https://doi.org/10.1038/s41392-021-00634-z |